Clinical Trial to Compare the Safety and Efficacy of Nanodrop®

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions

Dry Eye

Interventions

DRUG

Nanodrop®

minimum to meet 1 drop 4 times a day, both eyes

DRUG

Systane Balance

minimum to meet 1 drop 4 times a day, both eyes

Trial Locations (6)

Catarata y Glaucoma de Occidente, Guadalajara

Clínica de Investigación en Reumatología y Obesidad S.C., Guadalajara

Jose Navarro Partida, Guadalajara

Centro Potosino de Investigación Médica SC, San Luis Potosí City

Health Pharma Professional Research S.A. de C.V., Mexico City

Asociación para Evitar la Ceguera en México, I.A.P., Mexico City

All Listed Sponsors

lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT04111965 - Clinical Trial to Compare the Safety and Efficacy of Nanodrop® | Biotech Hunter | Biotech Hunter